IsoRay Revenue and Competitors

Richland, WA USA

Location

$13M

Total Funding

Estimated Revenue & Valuation

  • IsoRay's estimated annual revenue is currently $7.5M per year.(i)
  • IsoRay's estimated revenue per employee is $170,455
  • IsoRay's total funding is $13M.

Employee Data

  • IsoRay has 44 Employees.(i)
  • IsoRay grew their employee count by -32% last year.

IsoRay's People

NameTitleEmail/Phone
1
VP, Quality Assurance & Regulatory AffairsReveal Email/Phone
2
Sr. Director Applied Sciences, Radiation Safety OfficerReveal Email/Phone
3
Sr. Production Manager at Isoray Medical, Inc.Reveal Email/Phone
4
Innovators in seed brachytherapy and medical radioisotope applicationsReveal Email/Phone
5
Senior Radiation ScientistReveal Email/Phone
6
Human Resources CoordinatorReveal Email/Phone
7
Quality System SpecialistReveal Email/Phone
8
Member Technical StaffReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M39117%$14.9MN/A
#2
$44.9M143-30%$211.3MN/A
#3
$54M17211%$35.5MN/A
#4
$4.3M17-19%N/AN/A
#5
$18.3M73N/AN/AN/A
#6
$8.3M336%N/AN/A
#7
$81.1M32317%N/AN/A
#8
$7M28-12%N/AN/A
#9
$204.8M8163%N/AN/A
#10
$6.3M5025%$27.5MN/A
Add Company

What Is IsoRay?

IsoRay, a Richland, Washington based company, was founded in 1998 to commercialize proprietary isotope and manufacturing technology.IsoRay MedicalTM was founded in Richland, Washington in 1998, to develop, manufacture, and market isotopes for use in the medical treatment of various malignant diseases. The company’s founders included many recognized experts in the medical isotope field. Lane A. Bray, chief chemist of IsoRay MedicalTM, who developed the patented process for economically separating and purifying Cesium-131, was one of them.

keywords:N/A

$13M

Total Funding

44

Number of Employees

$7.5M

Revenue (est)

-32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

IsoRay News

2022-04-17 - Isoray (NYSE:ISR) Now Covered by StockNews.com

The firm set a “sell” rating on the stock. Isoray stock opened at $0.33 on Tuesday. The firm has a market cap of $47.30 million, a PE ratio of -...

2022-04-13 - Isoray, Inc. (NYSE:ISR) Expected to Post Earnings of -$0.01 Per Share

Isoray also reported earnings per share of ($0.01) during the same quarter last year. The firm is expected to report its next quarterly earnings...

2022-04-13 - Isoray, Inc. (NYSE:ISR) Expected to Announce Quarterly Sales of ...

Three analysts have issued estimates for Isoray's earnings, with the lowest sales estimate coming in at $2.90 million and the highest estimate...

2021-09-21 - Isoray : Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results

Record Full Year Revenue Fiscal Fourth Quarter Revenue Increased 19% Year-Over-Year RICHLAND, WASHINGTON - September 21, 2021 - Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today an ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.7M450%N/A
#2
$9.9M462%N/A
#3
$7.7M462%N/A
#4
N/A479%N/A
#5
$11.4M497%N/A